- Home
- CRGX vs GRNT Comparison
CRGX vs GRNT Comparison
Compare CRGX & GRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- GRNT
- Stock Information
- Founded
- CRGX 2021
- GRNT 2013
- Country
- CRGX United States
- GRNT United States
- Employees
- CRGX N/A
- GRNT N/A
- Industry
- CRGX
- GRNT Blank Checks
- Sector
- CRGX
- GRNT Finance
- Exchange
- CRGX Nasdaq
- GRNT Nasdaq
- Market Cap
- CRGX 964.5M
- GRNT 856.4M
- IPO Year
- CRGX 2023
- GRNT N/A
- Fundamental
- Price
- CRGX $12.81
- GRNT $5.72
- Analyst Decision
- CRGX Strong Buy
- GRNT Buy
- Analyst Count
- CRGX 6
- GRNT 3
- Target Price
- CRGX $31.80
- GRNT $7.60
- AVG Volume (30 Days)
- CRGX 224.8K
- GRNT 501.7K
- Earning Date
- CRGX 11-12-2024
- GRNT 11-07-2024
- Dividend Yield
- CRGX N/A
- GRNT 7.67%
- EPS Growth
- CRGX N/A
- GRNT N/A
- EPS
- CRGX N/A
- GRNT 0.36
- Revenue
- CRGX N/A
- GRNT $358,521,000.00
- Revenue This Year
- CRGX N/A
- GRNT $4.66
- Revenue Next Year
- CRGX N/A
- GRNT $22.97
- P/E Ratio
- CRGX N/A
- GRNT $16.57
- Revenue Growth
- CRGX N/A
- GRNT N/A
- 52 Week Low
- CRGX $13.10
- GRNT $5.20
- 52 Week High
- CRGX $33.92
- GRNT $7.10
- Technical
- Relative Strength Index (RSI)
- CRGX 30.99
- GRNT 39.28
- Support Level
- CRGX $13.33
- GRNT $5.91
- Resistance Level
- CRGX $15.26
- GRNT $6.20
- Average True Range (ATR)
- CRGX 1.36
- GRNT 0.15
- MACD
- CRGX -0.30
- GRNT -0.05
- Stochastic Oscillator
- CRGX 3.51
- GRNT 18.03
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.